Stockscreener 앱 받기
5.42
7.11%
0.36
시간 외 거래:
5.39
-0.03
-0.55%
전일 마감가:
$5.06
열려 있는:
$5.13
하루 거래량:
6.06M
Relative Volume:
3.68
시가총액:
$540.50M
수익:
$58.36M
순이익/손실:
$-25.72M
주가수익비율:
-14.89
EPS:
-0.3641
순현금흐름:
$-24.91M
1주 성능:
+43.77%
1개월 성능:
+37.56%
6개월 성능:
+94.27%
1년 성능:
+28.13%
1일 변동 폭
$5.11
$5.48
1주일 범위
$3.74
$5.48
52주 변동 폭
$2.12
$5.80
Aquestive Therapeutics Inc Stock (AQST) Company Profile
명칭
Aquestive Therapeutics Inc
전화
908-941-1900
주소
30 TECHNOLOGY DRIVE, WARREN, NJ
AQST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
5.42 | 612.13M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | Raymond James | Outperform |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2019-04-22 | 개시 | H.C. Wainwright | Buy |
| 2019-01-03 | 개시 | Lake Street | Buy |
| 2018-08-20 | 개시 | JMP Securities | Mkt Outperform |
| 2018-08-20 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
Aquestive Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Fed Impact & AI Powered Market Entry Strategies - Newser
Aquestive Therapeutics: Expect Its Torrid Pace To Relax (Rating Downgrade) (NASDAQ:AQST) - Seeking Alpha
Is Aquestive Therapeutics Inc. stock good for income investorsJuly 2025 Volume & AI Enhanced Trading Alerts - خودرو بانک
What are Aquestive Therapeutics Inc.’s recent SEC filings showingEarnings Growth Summary & Long-Term Capital Growth Strategies - خودرو بانک
Is Aquestive Therapeutics Inc. stock a smart retirement pickWeekly Investment Summary & Capital Protection Trading Alerts - خودرو بانک
Can Aquestive Therapeutics Inc. grow without external fundingJuly 2025 Breakouts & AI Powered Buy/Sell Recommendations - خودرو بانک
Aquestive jumps as FDA says no AdCom for allergy therapy Anaphylm - MSN
AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA - sharewise.com
Aquestive Therapeutics' Strategic Path to Anaphylm Approval and Market Capture - AInvest
Aquestive Therapeutics: No AdCom For Anaphylm Derisks January Approval Catalyst (AQST) - Seeking Alpha
Should you wait for a breakout in Aquestive Therapeutics Inc.Weekly Stock Analysis & Smart Investment Allocation Insights - Newser
News impact scoring models applied to Aquestive Therapeutics Inc.Share Buyback & Verified Entry Point Detection - Newser
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable - simplywall.st
Aquestive Therapeutics shares rise 2.17% premarket after FDA waives advisory committee meeting for Anaphylm. - AInvest
What Fibonacci levels say about Aquestive Therapeutics Inc. reboundTrade Analysis Report & Community Consensus Trade Signals - Newser
FDA won’t require advisory committee meeting for Aquestive’s anaphylaxis film - Investing.com Canada
Aquestive gains as allergy therapy undergoes FDA review - MSN
Evaluating Aquestive Therapeutics Inc. with trendline analysis2025 Market Trends & Low Drawdown Investment Ideas - Newser
Why Is Aquestive Therapeutics Stock Soaring Thursday?Aquestive Therapeutics (NASDAQ:AQST) - Benzinga
Aquestive Therapeutics Shares Rise, FDA Forgos Meeting on Anaphylm - MarketScreener
Aquestive Therapeutics shares surge 21.39% intraday after FDA waives advisory committee meeting for Anaphylm, a device-free, sublingual epinephrine film for severe allergic reactions. - AInvest
Analyzing recovery setups for Aquestive Therapeutics Inc. investorsJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - Newser
Aquestive Therapeutics, Inc. Announces FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm?? - MarketScreener
Aquestive Therapeutics Shares Soar 20% on FDA Approval Pathway - AInvest
Aquestive says no FDA AdCom for Anaphylm (AQST:NASDAQ) - Seeking Alpha
Aquestive climbs after US FDA says no advisory panel needed for epinephrine film - TradingView
Aquestive Therapeutics Announces that FDA Will Not Require - GlobeNewswire
First-Ever Needle-Free Epinephrine Film: Aquestive's Anaphylm Clears Key FDA Hurdle Without Committee Review - Stock Titan
Will Aquestive Therapeutics Inc. stock recover after recent dropMarket Growth Summary & Risk Managed Trade Strategies - Newser
Measuring Aquestive Therapeutics Inc.’s beta against major indicesEarnings Beat & Stepwise Trade Signal Implementation - Newser
How moving averages guide Aquestive Therapeutics Inc. tradingJuly 2025 Institutional & Stepwise Swing Trade Plans - Newser
Published on: 2025-09-03 22:42:37 - Newser
Can Aquestive Therapeutics Inc. ride the EV waveSell Signal & Intraday High Probability Alerts - خودرو بانک
What momentum shifts mean for Aquestive Therapeutics Inc.Weekly Trend Summary & Safe Capital Growth Plans - Newser
Risk adjusted return profile for Aquestive Therapeutics Inc. analyzed2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - Newser
Live market analysis of Aquestive Therapeutics Inc.Gold Moves & Accurate Intraday Trade Tips - Newser
Is Aquestive Therapeutics Inc. forming a reversal patternM&A Rumor & Short-Term High Return Strategies - Newser
Aquestive Therapeutics Inc. stock prediction for this week2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
Regression analysis insights on Aquestive Therapeutics Inc. performanceWeekly Loss Report & Verified Momentum Watchlists - Newser
Momentum divergence signals in Aquestive Therapeutics Inc. chart - Newser
Can Aquestive Therapeutics Inc. continue delivering strong returns2025 Big Picture & AI Powered Market Entry Ideas - khodrobank.com
Is Aquestive Therapeutics Inc. stock entering bullish territoryJuly 2025 Outlook & AI Optimized Trade Strategies - Newser
Aquestive Therapeutics Inc. recovery potential after sell offPortfolio Gains Report & Risk Managed Investment Strategies - Newser
Can Aquestive Therapeutics Inc. hit a new high this monthEarnings Growth Report & Safe Capital Growth Tips - Newser
Comparing Aquestive Therapeutics Inc. in custom built stock radarsJuly 2025 Big Picture & Low Drawdown Investment Ideas - Newser
Aquestive Therapeutics Inc. stock daily chart insightsJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser
Aquestive Therapeutics Inc (AQST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.53%
자본화:
|
볼륨(24시간):